Endoscopic Sclerotherapy versus Portacaval Shunt in Patients with Severe Cirrhosis and Variceal Hemorrhage

Authors:
  • JCJohn P. Cello
    John P. Cello
  • JGJames H. Grendell
    James H. Grendell
  • RCRichard A. Crass
    Richard A. Crass
  • DTDonald D. Trunkey
    Donald D. Trunkey
  • ECEdith E. Cobb
    Edith E. Cobb
  • DHDavid C. Heilbron
    David C. Heilbron
Publisher website
Google Scholar
Abstract
Fifty-two patients with severe cirrhosis (Child Class C) and variceal hemorrhage requiring six or more units of blood were randomly assigned to either sclerotherapy or portacaval shunt. Of 38 pretreatment characteristics, only the frequency of active alcoholism differed significantly between the groups. During the initial hospitalization, the patients in the shunt group required significantly more blood (21.5±3.1 units) than did those in the sclerotherapy group (12.3±1.3 units), although the latter had significantly more rebleeding during hospitalization after the procedure (14 of 28 vs. 5 of 24 patients). There was no difference in short-term survival, with 13 patients in the sclerotherapy group discharged alive, as compared with 10 patients in the shunt group.

This publication has 13 references indexed in Scilit: